Raymond Townsend

This profile gathers the share dealings of Raymond Townsend in Kindred Biosciences, Inc., where the filings describe the role as board member. Between 12 December 2013 and 27 August 2021, the trades on record add up to 21 filings.

In open-market terms, that means 6 purchases worth €58k on one side and 6 sales worth €106k on the other. Taken together, the sales exceed the purchases by €47k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 8 option exercises.

Half of the purchases are above €9,580 and half below.

The newest entry dates from 30 August 2021: a transaction of €196k, in Kindred Biosciences, Inc. The clock since the last published purchase (24 November 2015) now reads 3,986 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.